Cargando…

Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome

The Hyperphagia Questionnaire for Clinical Trials (HQ-CT) is an observer-reported outcome measure that has been widely used in interventional studies to assess changes in hyperphagic behaviors in individuals with Prader-Willi syndrome (PWS). However, HQ-CT scores in the wider PWS population and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matesevac, Lisa, Vrana-Diaz, Caroline J., Bohonowych, Jessica E., Schwartz, Lauren, Strong, Theresa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667498/ https://www.ncbi.nlm.nih.gov/pubmed/37996659 http://dx.doi.org/10.1038/s41598-023-48024-5

Ejemplares similares

Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
por: Kayadjanian, Nathalie, et al.
Publicado: (2021)

Thrombosis Risk History and D-dimer Levels in Asymptomatic Individuals with Prader–Willi Syndrome
por: Matesevac, Lisa, et al.
Publicado: (2022)

Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015)

Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry
por: Bohonowych, Jessica E., et al.
Publicado: (2021)

Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data
por: Peleggi, Analise, et al.
Publicado: (2021)

Prader-Willi syndrome mental health research strategy workshop proceedings: the state of the science and future directions
por: Schwartz, Lauren, et al.
Publicado: (2016)

The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome
por: Licenziati, Maria Rosaria, et al.
Publicado: (2022)

The Global Prader–Willi Syndrome Registry: Development, Launch, and Early Demographics
por: Bohonowych, Jessica, et al.
Publicado: (2019)

Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
por: Polex-Wolf, Joseph, et al.
Publicado: (2018)

Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?
por: Ramos-Molina, Bruno, et al.
Publicado: (2018)

Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome
por: Cho, Sung Yoon, et al.
Publicado: (2022)

Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study
por: Vrana-Diaz, Caroline J., et al.
Publicado: (2020)

Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader‐Willi syndrome
por: Kweh, Frederick A., et al.
Publicado: (2023)

High levels of caregiver burden in Prader-Willi syndrome
por: Kayadjanian, Nathalie, et al.
Publicado: (2018)

Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader–Willi syndrome
por: Davies, Jennifer R., et al.
Publicado: (2015)

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
por: Roof, Elizabeth, et al.
Publicado: (2023)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

Venous Thromboembolism in Prader–Willi Syndrome: A Questionnaire Survey
por: Manzardo, Ann M., et al.
Publicado: (2019)

The High Direct Medical Costs of Prader-Willi Syndrome
por: Shoffstall, Andrew J., et al.
Publicado: (2016)

Three Siblings with Prader-Willi Syndrome: Brief Review of Sleep and Prader-Willi Syndrome
por: Bingeliene, Arina, et al.
Publicado: (2015)

Do the diverse phenotypes of Prader-Willi syndrome reflect extremes of covariation in typical populations?
por: Salminen, Iiro, et al.
Publicado: (2022)

Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS)
por: Ryman, Davis, et al.
Publicado: (2021)

Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
por: Cheon, Chong Kun
Publicado: (2016)

Epigenetics in Prader-Willi Syndrome
por: Mendiola, Aron Judd P., et al.
Publicado: (2021)

Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
por: Schwartz, Lauren, et al.
Publicado: (2021)

Prader-Willi Syndrome: Clinical Aspects
por: Elena, Grechi, et al.
Publicado: (2012)

Hyperprolactinemia in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Sleep Consequences of Prader-Willi Syndrome
por: Itani, Reem, et al.
Publicado: (2023)

Grey matter volume and cortical structure in Prader-Willi syndrome compared to typically developing young adults
por: Manning, Katherine E., et al.
Publicado: (2017)

Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey
por: Butler, Merlin G., et al.
Publicado: (2016)

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosis
por: Heseding, Hannah M., et al.
Publicado: (2022)

Prader-Willi syndrome: A primer for clinicians
por: Cataletto, Mary, et al.
Publicado: (2011)

Prader-Willi Syndrome and Growth Hormone Deficiency
por: Aycan, Zehra, et al.
Publicado: (2014)

Endocrine manifestations and management of Prader-Willi syndrome
por: Emerick, Jill E, et al.
Publicado: (2013)

Clinical and laboratory characteristics of Prader-Willi syndrome
por: Thao, Bui Phuong, et al.
Publicado: (2013)

Gall bladder agenesis in Prader Willi syndrome
por: Nair, Abilash, et al.
Publicado: (2015)

Adult Prader-Willi Syndrome: An Update on Management
por: Ho-Ming, Luk
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ur16mbjd1t3b3pet6vo16mknl9